Selective Treatment of Oral Povorcitinib Long-Term Rollover Study (STOP-LTR) A Phase 3b, Multicenter, Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib. INCB054707-801

Project: Research project

Project Details

Description

Selective Treatment of Oral Povorcitinib Long-Term Rollover Study (STOP-LTR) A Phase 3b, Multicenter, Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib. INCB054707-801
StatusActive
Effective start/end date3/14/255/29/35

Funding

  • INCYTE CORPORATION

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.